268
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Safety and outcomes of decompressive craniectomy after intravenous tissue plasminogen activator administration for malignant cerebral infarction

, , , &
Pages 274-276 | Received 15 Jun 2015, Accepted 21 Feb 2016, Published online: 21 Mar 2016

References

  • Saver JL, Goyal M, Bonafe A; SWIFT PRIME Investigators, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015;372:2285–95.
  • Baharvahdat H, Etemadrezaie H, Zabyhian S, et al. Decompressive craniectomy after unsuccessful intravenous thrombolysis of malignant cerebral infarction. Iran J Neurol 2014;13:101–4.
  • Takeuchi S, Wada K, Nawashiro H, et al. Decompressive craniectomy after intravenous tissue plasminogen activator administration for stroke. Clin Neurol Neurosurg 2012;114:1312–15.
  • Lijnen HR, Collen D. Tissue-type plasminogen activator. Ann Biol Clin (Paris) 1987;45:198–201.
  • Cucchiara B, Kasner SE, Tanne D; SAINT Investigators, et al. Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials. Stroke 2009;40:3067–72.
  • Hacke W, Kaste M, Bluhmki E; ECASS Investigators, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317–29.
  • Kurland DB, Khaladj-Ghom A, Stokum JA, et al. Complications associated with decompressive craniectomy: a systematic review. Neurocrit Care 2015;23:292–304.
  • Staykov D, Gupta R. Hemicraniectomy in malignant middle cerebral artery infarction. Stroke 2011;42:513–16.
  • Jüttler E, Schwab S, Schmiedek P, et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial. Stroke 2007;38:2518–25.
  • Hofmeijer J, Kappelle LJ, Algra A; HAMLET investigators, et al. Surgical decompression for space-occupying cerebral infarction (the hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol 2009;8:326–33.
  • Vahedi K, Hofmeijer J, Juettler E; DECIMAL, DESTINY, and HAMLET investigators, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007;6:215–22.
  • Yang XF, Wen L, Shen F, et al. Surgical complications secondary to decompressive craniectomy in patients with a head injury: a series of 108 consecutive cases. Acta Neurochirurgica 2008;150:1241–7.
  • Vahedi K, Vicaut E, Mateo J, et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke 2007;38:2506–17.
  • Schuss P, Borger V, Vatter H, et al. Antiplatelet therapy, but not intravenous thrombolytic therapy, is associated with postoperative bleeding complications after decompressive craniectomy for stroke. J Neurol 2013;260:2149–55.
  • Walcott BP, Kuklina EV, Nahed BV, et al. Craniectomy for malignant cerebral infarction: prevalence and outcomes in US hospitals. PLoS One 2011;6:e29193.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.